A clinical trial of BLU-667 for non-small cell lung cancer, medullary thyroid cancer and other RET-altered tumors.
A clinical trial of avapritinib versus regorafenib (Stivarga®) for people with advanced GIST that has progressed following first-line treatment with imatinib (Gleevec®) and one or two additional treatment regimens (third-line or fourth-line GIST).
Our SM Trials
We are conducting multiple clinical trials of avapritnib for people with SM. PATHFINDER is a clinical trial for people with advanced systemic mastocytosis. PIONEER is for people with indolent and smoldering mastocytosis.